IINN Overview

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

Wall Street analysts forecast IINN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IINN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Inspira Technologies Oxy BHN Ltd revenue for the last quarter amounts to -3.16M USD, decreased -3.78

Inspira Technologies Oxy BHN Ltd. EPS for the last quarter amounts to 0.69 USD, decreased

Inspira Technologies Oxy BHN Ltd (IINN) has 38 emplpoyees as of March 11 2026.

Today IINN has the market capitalization of 24.60M USD.